PETN improves to a minor extent vascular remodeling and endothelial function and more potently suppresses oxidative stress as well as pathological changes in heart/body and lung/body weight ratio in an experimental model of PAH by induction of HO-1 but also by interference with ET-1 signaling. The gene discussed is HMOX1; the disease is pulmonary arterial hypertension.